Arcadia Biosciences, Inc.
RKDANasdaqCIK 1469443EnergyFiscal year ends Dec 31
Reports and events: 223 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1515:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-391780 |
| 2026-09-0416:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-383642 |
| 2026-08-1316:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349205 |
| 2026-08-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349180 |
| 2026-08-1016:17 ET | DEF 14A | Proxy statementPeriod 2026-08-10 | 0001193125-26-342437 |
| 2026-08-1018:49 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-340664 |
| 2026-07-0216:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-294619 |
| 2026-06-1511:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-270560 |
| 2026-05-1416:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-223990 |
| 2026-05-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-223985 |
| 2026-04-3016:14 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-197315 |
| 2026-04-0315:31 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-142030 |
| 2026-03-2616:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-126238 |
| 2026-03-2616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126220 |
| 2026-02-0616:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-041144 |
| 2026-01-1420:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-012028 |
| 2025-12-2916:30 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-335410 |
| 2025-12-2316:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-331009 |
| 2025-11-1916:30 ET | DEF 14A | Proxy statementPeriod 2025-12-19 | 0001193125-25-288164 |
| 2025-11-0716:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272375 |
| 2025-11-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-272368 |
| 2025-10-2415:13 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-249854 |
| 2025-08-2917:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-112267 |
| 2025-08-1417:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-109040 |
| 2025-08-1416:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108983 |
| 2025-05-1617:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-073711 |
| 2025-05-0808:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066425 |
| 2025-05-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066420 |
| 2025-05-0217:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-062913 |
| 2025-04-3016:08 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-061044 |
| 2025-04-0316:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-050406 |
| 2025-03-2516:44 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-044487 |
| 2025-03-2016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042647 |
| 2024-12-1117:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-135447 |
| 2024-12-0620:53 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-133817 |
| 2024-11-1217:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125613 |
| 2024-11-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125393 |
| 2024-08-2311:56 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-100065 |
| 2024-08-1317:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096439 |
| 2024-08-1316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096215 |
| 2024-08-0712:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-092432 |
| 2024-07-0816:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-082092 |
| 2024-07-0116:10 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-079602 |
| 2024-05-2016:33 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-24-062449 |
| 2024-05-1715:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-24-061526 |
| 2024-05-1614:13 ET | DEF 14A | Proxy statementPeriod 2024-05-16 | 0000950170-24-060967 |
| 2024-05-1315:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058563 |
| 2024-05-0916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056928 |
| 2024-04-2914:07 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-049710 |
| 2024-03-2817:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-038176 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.